Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells

被引:0
作者
Sara Cherradi
Véronique Garambois
Johanna Marines
Augusto Faria Andrade
Alexandra Fauvre
Olivia Morand
Manon Fargal
Ferial Mancouri
Adeline Ayrolles-Torro
Nadia Vezzo-Vié
Marta Jarlier
Gerald Loussaint
Steve Huvelle
Nicolas Joubert
Thibault Mazard
Céline Gongora
Philippe Pourquier
Florence Boissière-Michot
Maguy Del Rio
机构
[1] Institut de Recherche en Cancérologie de Montpellier,Biometry Department
[2] INSERM U1194,Department of Medical Oncology
[3] Université de Montpellier,Translational Research Unit
[4] Institut du Cancer de Montpellier,GICC, Team IMT
[5] ICM,undefined
[6] ICM,undefined
[7] ICM,undefined
[8] University of Tours,undefined
来源
Cell & Bioscience | / 13卷
关键词
Colorectal cancer; CLDN1; ADC; Chemotherapy; Resistance; “One-two punch”; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 279 条
  • [11] Chen Y-X(2016)Mechanisms of drug resistance in colon cancer and its therapeutic strategies World J Gastroenterol 22 6876-80
  • [12] Fang J-Y(2021)LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan Biomed Pharmacother 143 112091-94
  • [13] Vasan N(2018)CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231 Mol Cell Biochem 443 169-80
  • [14] Baselga J(2021)Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate Sci Transl Med 13 eabb6282-11
  • [15] Hyman DM(2013)Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1 Mol Pharmacol 83 85-37
  • [16] Yanagisawa Y(2018)Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells Biochim Biophys Acta Mol Cell Res 1865 769-304
  • [17] Maruta F(2006)Claudins: emerging targets for cancer therapy Expert Rev Mol Med 8 1-51
  • [18] Iinuma N(2017)Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer J Hematol Oncol 10 105-6
  • [19] Ishizone S(2017)Antibody targeting of claudin-1 as a potential colorectal cancer therapy J Exp Clin Cancer Res 36 89-46
  • [20] Koide N(2018)Two-step senescence-focused cancer therapies Trends Cell Biol 28 723-12